Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1998-3-30
|
pubmed:abstractText |
The oxidation of cytosine in DNA by free radicals and other oxidants leads to an assortment of products including pyrimidine ring 5,6-saturated, 5,6-unsaturated, contraction, and fragmentation products. The formation of these products in cellular DNA may explain in part the preponderance of C to T transitions induced spontaneously and by H2O2 or ionizing radiation. Our studies have focused on the biological effects of two major 5,6-unsaturated oxidation products of cytosine: 5- hydroxycytosine and 5-hydroxyuracil. In the present work, we have attempted to study the repair of these two lesions by specifically incorporating them into cellular DNA upon incubation of cells with 5-hydroxy-2'deoxycytidine and 5-hydroxy-2'-deoxyuridine. Incubation of mouse L1210 cells with 250 M 5-hydroxy-2'-deoxycytidine led to the incorporation of this lesion to a level 20 times higher (43 lesions/10(5) cytosines) than base-line levels; however, there was no evidence for its repair following a 15-h chase. In contrast, we did not observe any significant incorporation of 5-hydroxy-2'-deoxyuridine into the DNA of L1210 cells but did observe an unidentified product, presumably an oxidation product. This unidentified pyrimidine was incorporated at a very high level (about 2000 lesions/10(5) cytosine residues) and then partially repaired in chase experiments.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/5-hydroxy-2'-deoxycytidine,
http://linkedlifedata.com/resource/pubmed/chemical/5-hydroxy-2'-deoxyuridine,
http://linkedlifedata.com/resource/pubmed/chemical/DNA,
http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine,
http://linkedlifedata.com/resource/pubmed/chemical/Deoxyuridine
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0829-8211
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
75
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
377-81
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9493960-Animals,
pubmed-meshheading:9493960-DNA,
pubmed-meshheading:9493960-DNA Damage,
pubmed-meshheading:9493960-DNA Repair,
pubmed-meshheading:9493960-Deoxycytidine,
pubmed-meshheading:9493960-Deoxyuridine,
pubmed-meshheading:9493960-HeLa Cells,
pubmed-meshheading:9493960-Humans,
pubmed-meshheading:9493960-Jurkat Cells,
pubmed-meshheading:9493960-Leukemia L1210,
pubmed-meshheading:9493960-Mice,
pubmed-meshheading:9493960-Oxidation-Reduction
|
pubmed:year |
1997
|
pubmed:articleTitle |
Incorporation of two deoxycytidine oxidation products into cellular DNA.
|
pubmed:affiliation |
Institut universitaire de gériatrie de Sherbrooke, QC, Canada. rwagner@courrier.usherb.ca
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|